Little Green Pharma Ltd banner

Little Green Pharma Ltd
ASX:LGP

Watchlist Manager
Little Green Pharma Ltd Logo
Little Green Pharma Ltd
ASX:LGP
Watchlist
Price: 0.092 AUD -3.16% Market Closed
Market Cap: AU$28.1m

Little Green Pharma Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Little Green Pharma Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Little Green Pharma Ltd
ASX:LGP
Research & Development
-AU$290k
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Research & Development
-AU$17.9m
CAGR 3-Years
-14%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Research & Development
-AU$36.4m
CAGR 3-Years
-42%
CAGR 5-Years
-36%
CAGR 10-Years
-10%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Research & Development
-AU$66.9m
CAGR 3-Years
-52%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
Vita Life Sciences Ltd
ASX:VLS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Little Green Pharma Ltd
Glance View

Market Cap
28.1m AUD
Industry
Pharmaceuticals

Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The Company’s products includes LGP Classic range and LGP Flower range. Its LGP Classic range includes tetrahydrocannabinol (THC) and cannabidiol (CBD) ratios presented in an oil formulation. Its LGP Flower range is grown and manufactured in the Southwest of Western Australia and supplied as dried medicinal cannabis whole flowers. The firm supplies medical-grade cannabis products to Australian, European and overseas markets. The company is also engaged in promoting education and outreach programs.

LGP Intrinsic Value
0.181 AUD
Undervaluation 49%
Intrinsic Value
Price

See Also

What is Little Green Pharma Ltd's Research & Development?
Research & Development
-290k AUD

Based on the financial report for Mar 31, 2025, Little Green Pharma Ltd's Research & Development amounts to -290k AUD.

What is Little Green Pharma Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
62%

Over the last year, the Research & Development growth was 95%. The average annual Research & Development growth rates for Little Green Pharma Ltd have been 62% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett